Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
When I’m looking through the lens and—excuse the pun—focusing on what’s in front of me, I’m not thinking about cancer. At. all.
Missing data from a clinical trial on a new diagnostic test for prostate cancer risk have researchers calling one another out.
Join us for a wonderful evening of friendship and awarenessin the fight against prostate cancer.
How a baseball broadcaster brought his career and advocacy together to educate men about early detection of prostate cancer
Just for grins and giggles, I asked her the $64,000 question: How do you define biochemical recurrence?
The Colorado senator announced his candidacy this month.
When I went into planning this, it was a bucket list trip of sorts. But then my PSA results came back and it became more of a celebration.
Both new cases and mortality have declined or stabilized in most countries.
New genetic testing from Invitae shows how genetic abnormalities in prostate cancer patients can affect both future and family cancer risks.
If you’re not going to acknowledge reader comments, why bother giving us the option to do comment in the first place?
I can’t wait to hear what the urologist has to say about this on 18 April.
What may be good for business is bad for patient care — and certainly disquieting for those whose health care providers simply disappear.
I should have the results of my next PSA test by Friday.
Mental health care before cancer treatment is associated with higher death rates for those with kidney, prostate or bladder cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.